Angeles University Foundation Medical Center

Results 1 - 24 of 24
Public Title Project Description Modified
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy . . . Phase 3, multicenter, randomized, double-blind, placebocontrolled, parallel-group, outpatient study . . . 14 Sep 2016 12:56:53
A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane . . . Study H9B-MC-BCDX (BCDX) is an open-label extension (OLE) study that assesses the longterm safety an . . . 01 Dec 2015 03:48:40
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURI . . . The primary hypothesis is that additional LDL-C lowering with AMG 145 when used in addition to other . . . 08 Apr 2016 09:34:32
A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Int . . . This is a global, multi-center, randomized, placebo-controlled study to evaluate adverse events of s . . . 22 Aug 2018 08:56:43
A randomized, double-blind placebo-controlled study of the maintenance of efficacy of etanercept plu . . . The combination of ETN 50 mg once weekly plus MTX ( other DMARDs) therapy with that of MTX ( o . . . 14 Sep 2016 01:20:24
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to . . . This is a Phase IIb, multicenter, double-blind, placebocontrolled (DBPC) parallel-arm trial in which . . . 12 Oct 2015 01:56:42
A Phase IIb, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atac . . . This is a phase IIb, multi-center, LTE trial in which subjects will receive atacicept 75 or 150 mg, . . . 18 Jan 2018 10:58:09
BI695501 compared to adalimumab in patients with active rheumatoid arthritis Clinical Phase: IIIDuration of treatment: Each patient will be treated with either BI 695501 or US-s . . . 14 Aug 2015 01:24:06
A randomised, double-blind, active-controlled parallel group study to evaluate the effect of 52 week . . . Phase IIIbStudy Duration: 24 monthsThis study is a randomised, double-blind, active-controlled paral . . . 21 Mar 2017 01:48:07
A 26 week, randomized, active-controlled safety study of double-blind formoterol fumarate in free co . . . Study of safety of Foradil in patients with persistent asthma. 05 May 2016 11:01:29
A phase 3 double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy, . . . This study is a Phase 3, double blind, placebo controlled, randomized, stratified, parallel group, m . . . 21 Nov 2016 01:36:51
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK- . . . This is a randomized, placebo-controlled, parallel-group, multi-center, double-blind, event driven s . . . 02 Jan 2019 10:53:01
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 i . . . This is a phase 2, randomized, double-blind, placebo-controlled study evaluating the efficacy and sa . . . 18 Sep 2018 04:24:06
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoi . . . Study A391192 is a phase 3b/4 randomized double blind placebo controlled study of methotrexate (MTX) . . . 19 Mar 2019 04:49:20
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety a . . . This is a Phase II, multicenter, international, randomized, double-blind, placebo-controlled (DBPC) . . . 14 Jan 2019 03:58:36
A multicenter, randomized, double-blind, active-controlled, parallel-group phase 3 study to evaluat . . . A multicenter, randomized, double-blind, active-controlled, parallel-group phase 3 study to evaluat . . . 07 Jul 2017 09:21:11
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin . . . This is a Phase 3, multicenter, randomized, prospective, double-blind, parallel-group, placebo-contr . . . 15 Feb 2018 08:19:39
A STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH CONNECTIVE TISSUE DISEASE- . . . This double-blind, randomized, placebo-controlled trial will study the safety, tolerability, and eff . . . 30 Apr 2019 02:55:20
Dose-finding, efficacy and safety of BI 655064 in patients with active lupus nephritis This study is a Multi-national, randomized, double-blind, placebo-controlled, 4 parallel group in . . . 12 Jan 2018 02:51:14
A Phase III Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-centre, Multinationa . . . This is a phase III randomized, double Blind, Parallel Group, placebo controlled study to evaluate e . . . 23 Oct 2018 02:44:42
An Extended Access Program to Assess Long-Term Safety of Bardoxolone Methyl in Patients with Pulmona . . . This extended access study will assess the long-term safety and tolerability of bardoxolone methyl i . . . 26 Feb 2018 04:14:32
A Randomized, Controlled, Double-blind, Continuation Study Comparing the Long-term Safety and Effica . . . The aim of the Phase 3 continuation study (AURORA 2) is to assess the long-term safety and tolerabil . . . 28 Jul 2018 10:42:53
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standar . . . Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standar . . . 30 Nov -0001 12:00:00
An exploratory maintenance trial of BI 655064 in patients with lupus nephritis This is a phase II, randomised, double-blind, parallel-design, dose-ranging, placebocontrolled, exp . . . 27 May 2019 11:05:42

Copyright © One Window Project 2018. All rights reserved.